Stock GOSS GOSSAMER BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
0.694 USD -4.93% Intraday chart for Gossamer Bio, Inc. -6.51% -23.95%
05-07 Gossamer Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Chiesi Farmaceutici S.P.A Gossamer Bio, Inc Announces Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pulmonary Arterial Hypertension and Other Respiratory Indications CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. GOSS Stock
  4. News Gossamer Bio, Inc.
  5. Official Publications